Targeting COVID-19,MERS,and SARS with a Universal Vaccine Strategy

摘要

In recent years,we have faced unprecedented threats by coronavirus(CoV)infections,particularly the ongoing COVID-19 pandemic.To fight back,scientists at the Institute of Microbiology,CAS(IMCAS)together with their collaborators developed a universal vaccine strategy against COVID-19,MERS,and SARS.Animal study showed promising results,and a vaccine candidate against COVID-19 based on this strategy has thereby proceeded to phase II clinical study.